Durect DRRX 深 滬
等待開盤 09-20 09:30:00 美东时间
1.37
+0.020
+1.48%
華盛通- 最 高1.4212
- 今 開1.42
- 成交量 8.90万股
- 最 低 1.33
- 昨 收 1.35
- 總市值 4086.56万
- 52周最高 3.14
- 市盈率 靜 --
- 換手率 0.30%
- 52周最低 0.4703
- 委 比 74.36%
- 總股本 2982.89万
- 歷史最高 39.49
- 量 比 0.99
- 振 幅 6.76%
- 歷史最低 0.4703
- 每 手 1
- 風險率 0.63%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多DURECT Corporation to Present at the H.C. Wainwright Global Investment Conference
CUPERTINO, Calif., Sept. 4, 2024 /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX), a late-stage biopharmaceutical company pioneering the development of epigenetic therapies to transform the...
09-05 04:30
Here's the major earnings after the close today
Major earnings expected after the bell on Tuesday include: Ouster (OUST) Franco-Nevada Corporation (FNV) Asensus Surgical (ASXC) Westport Fuel Systems (WPRT) HIVE Digital Technologies Ltd. (HIVE) Othe...
08-13 22:00
Durect Grants CFO Tim Papp Incentive Stock Package
Durect (DRRX) just unveiled an announcement. DURECT Corporation’s board, on the...
07-31 04:59
DURECT gets FDA breakthrough therapy status for larsucosterol
DURECT (NASDAQ:DRRX) has received FDA breakthrough therapy designation for its drug candidate larsucosterol in the treatment of severe alcohol-related hepatitis. The drug developer plans to present ad...
05-21 22:10
ASTS, ALLO and CMCM are among premarket gainers
Gainers: Biodexa Pharmaceuticals (BDRX) +61%. Edible Garden (EDBL) +48%. Meta Materials (MMAT) +34% Announces Update on Naked Short Selling Investigation. Mmtec (MTC) +24%. Larimar Therapeutics (...
05-21 20:26
Cutera, Inotiv, Treace Medical Concepts among healthcare movers
Gainers: Harrow (HROW) +26%. Treace Medical Concepts (TMCI) +25%. Syra Health (SYRA) +23%. Delcath Systems (DCTH) +21%. Cutera (CUTR) +16%. Losers: Inotiv (NOTV) -55%. Augmedix (AUGX) -54%. Akoya Bios...
05-14 22:00
Durect (DRRX) Gets a Buy from Oppenheimer
Oppenheimer analyst Francois Brisebois maintained a Buy rating on Durect (DRRX ...
05-14 19:56
Oppenheimer Reiterates Outperform on Durect, Maintains $5 Price Target
Oppenheimer analyst Francois Brisebois reiterates Durect (NASDAQ:DRRX) with a Outperform and maintains $5 price target.
04-01 21:19
HC Wainwright & Co. Reiterates Neutral on Durect
HC Wainwright & Co. analyst Ed Arce reiterates Durect (NASDAQ:DRRX) with a Neutral.
03-28 20:11
H.C. Wainwright Keeps Their Hold Rating on Durect (DRRX)
H.C. Wainwright analyst Ed Arce maintained a Hold rating on Durect (DRRX – Rese...
03-28 18:27
